Compounds > prednisone
Page last updated: 2024-08-17

prednisone and stilbenes

prednisone has been researched along with stilbenes in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
PECHERSTORFER, M1
Bellanger, C; Bordessoule, D; Feuillard, J; Gourin-Chaury, MP; Jauberteau, MO; Marin, B; Olivrie, A; Petit, B; Petit, D; Troutaud, D1
Iwamoto, M; Pacifici, M; Sinha, S; Uchibe, K; Usami, Y1
Cui, L; Hu, ZQ; Lai, WX; Li, J; Liang, YL; Liu, YY; Mo, YL; Wang, DT; Yang, YJ; Yu, YJ; Zhang, XL; Zhu, Z1

Other Studies

4 other study(ies) available for prednisone and stilbenes

ArticleYear
[Experiences with combined hormonal treatment of prostate carcinoma].
    Wiener medizinische Wochenschrift (1946), 1959, Feb-07, Volume: 109, Issue:6

    Topics: Combined Modality Therapy; Humans; Male; Prednisone; Prostatic Neoplasms; Stilbenes

1959
Prognostic significance of BAD and AIF apoptotic pathways in diffuse large B-cell lymphoma.
    Clinical lymphoma, myeloma & leukemia, 2010, Volume: 10, Issue:2

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Inducing Factor; B-Lymphocytes; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Prognosis; Rituximab; Stilbenes; Vincristine

2010
Effectiveness and mode of action of a combination therapy for heterotopic ossification with a retinoid agonist and an anti-inflammatory agent.
    Bone, 2016, Volume: 90

    Topics: Animals; Anti-Inflammatory Agents; Body Weight; Cartilage; Cell Movement; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Genes, Reporter; Macrophages; Mast Cells; Mice, Inbred C57BL; NF-kappa B; Ossification, Heterotopic; Prednisone; Pyrazoles; Retinoids; Stilbenes; Transfection; Treatment Outcome

2016
Tanshinol alleviates impaired bone formation by inhibiting adipogenesis via KLF15/PPARĪ³2 signaling in GIO rats.
    Acta pharmacologica Sinica, 2018, Volume: 39, Issue:4

    Topics: Adipocytes; Adipogenesis; Animals; Body Weight; Bone Marrow; Caffeic Acids; CCAAT-Enhancer-Binding Protein-alpha; Down-Regulation; Fatty Acid-Binding Proteins; Female; Forkhead Box Protein O3; Kruppel-Like Transcription Factors; Osteogenesis; Osteoporosis; PPAR gamma; Prednisone; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Up-Regulation; Wnt Signaling Pathway

2018